1 INTRODUCTIONKawasaki Disease (KD) is a rare entity but one of the most common pediatric vasculitis. It predominantly affects the pediatric population, generally before the age of 5 years with coronary artery aneurysms being the most feared complication; however, due to the broader disease spectrum, patients can present with diverse clinical presentations [1]. Coronary aneurysms generally develop after two weeks of disease onset in about 25% of cases [2]. The standard treatment includes IV immunoglobulin and aspirin [3]. There are no specific laboratory markers and the diagnosis is mainly based on a set of clinical criteria, featuring prolonged fever, polymorphous rash, conjunctivitis, mucosal changes, lymphadenopathy, and extremity changes [4]. Systemic arterial aneurysm formation is a very rare entity, affecting 0.8% to 2% of the cases, approximately 3 months after disease onset [5].